.jpg "Cross Country Healthcare (NASDAQ: CCRN)")
In a report released today, Kevin Steinke from Barrington maintained a Buy rating on Cross Country Healthcare (NASDAQ: CCRN), with a price target of $15. The company’s shares closed yesterday at $12.27.
According to TipRanks.com, Steinke is a 3-star analyst with an average return of 6.2% and a 53.8% success rate. Steinke covers the Services sector, focusing on stocks such as Echo Global Logistics, Heidrick & Struggles, and Navigant Consulting.
Cross Country Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $12.80.
See today’s analyst top recommended stocks >>
Based on Cross Country Healthcare’s latest earnings release for the quarter ending March 31, the company reported a quarterly net profit of $1.64 million. In comparison, last year the company had a GAAP net loss of $2.01 million.
Based on the recent corporate insider activity of 52 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CCRN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cross Country Healthcare, Inc. engages in the provision of healthcare staffing and workforce management solutions. It operates through the following segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services.
